FDA approves new HIV treatment for patients who have limited treatment options - FDA Press Releases

The FDA approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies.

from Food and Drug Administration--Press Releases http://ift.tt/2Fwq6rd
via IFTTT